Microbe-based process for GBL nears commercialization
| By Scott Jenkins
Metabolix Inc. (Cambridge, Mass.; www.metabolix.com) has successfully demonstrated and completed research and development for scaleup on a fermentation process that produces gamma -butyrolactone (GBL) from genetically engineered bacteria.
The process…